March 4, 2011

NEW YORK — Sure, the plethora of proton-pump inhibitors dotting digestive aisles these days have generated plenty of buzz among antacids, but what do heartburn sufferers do while they wait for the PPI to begin working? They turn to an immediate relief option like the Tums and Tums Ultra brands, which together generated growth of 96.3% to $24.9 million for the 12 weeks ended Jan. 23 across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.

February 22, 2011

Prasco Labs will distribute an authorized generic version of an ulcerative colitis treatment made by Shire in the event that any other company steps forward to file an abbreviated new drug application for the drug.

February 10, 2011

The Food and Drug Administration will propose an amendment to the over-the-counter laxative monograph that sodium phosphate salts are not generally recognized as safe for bowel cleansing.

January 20, 2011

A recent clinical trial involving a new drug formulation incorporating aspirin with soy-derived phosphatidylcholine found that the drug combination significantly can reduce irritation to the stomach and upper gastrointestinal tract.

January 20, 2011

The Food and Drug Administration and Health Canada have granted priority review to a drug for treating hepatitis C.

January 17, 2011

A Food and Drug Administration advisory committee voted last week not to recommend approval of a drug from Eli Lilly.

December 22, 2010

The National Advertising Division of the Council of Better Business Bureaus on Tuesday ruled that Procter & Gamble provided reasonable support for claims that Prilosec OTC provides “superior acid control” over a competing product, Prevacid 24HR. However, the NAD recommended P&G discontinue a comparative claim made in a context that doesn’t reference acid control, the review board added.

December 16, 2010

An investigational treatment for irritable bowel syndrome could become a blockbuster by the end of the decade, according to a report by Decision Resources.

December 7, 2010

NEW YORK — Last year, the big question on every­one’s mind was: How many brands can actually thrive in what has become a cluttered antacid shelf? Because just exactly how many heartburn sufferers are there?


November 7, 2010

The Cystic Fibrosis Foundation announced on Monday that it will partner with CVS/pharmacy and Warner...

October 26, 2010

Drug maker Pharmaxis got promising results from an investigative treatment for cystic fibrosis, the company...

October 17, 2010

The Food and Drug Administration has approved an additional use for a hepatitis drug....

October 5, 2010

Enzymedica on Tuesday launched a campaign to drive awareness around enzymatic therapy as a way...

October 4, 2010

The drug market for ulcerative colitis treatments will see modest growth through 2019, according to...

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 26, 2010

Nutramax Labs recently launched its Samsyl dietary supplement for liver health. Samsyl contains a blend...

August 26, 2010

The Food and Drug Administration has approved a generic treatment for hypertension and liver cirrhosis...

August 19, 2010

An anti-inflammatory drug approved 60 years ago may help fight against a fungal infection of...

August 12, 2010

The Food and Drug Administration on Aug. 9 posted a video outlining the revised prescription...

August 8, 2010

An investigational drug in late-stage clinical trials increased the cure rate in patients with hepatitis...

July 20, 2010

Drug maker Eli Lilly has finished its acquisition of a company developing a pancreatic disorder...

July 5, 2010

HappyBaby has expanded its line of organic products with two new gluten-free varieties....

July 5, 2010

Drug maker Eli Lilly is moving to acquire a company developing an enzyme-replacement therapy, Lilly...

July 5, 2010

The Food and Drug Administration has approved a gastroesophageal reflux disease drug made by Lupin...